Viewing StudyNCT01198522

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 10:49 PM
Last Modification Date: 2024-10-26 @ 10:24 AM
Study NCT ID: NCT01198522
Status: TERMINATED
Last Update Posted: 2022-04-15
First Post: 2010-09-08
Brief Title: Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients
Sponsor: Philogen SpA
Organization: Philogen SpA
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection
Keywords:
Name View
L19 View
Interleukin IL2 Gemcitabine monoclonal antibody cytokine tumour targeting dose finding fusion protein Pancreatic cancer View